Advertisement
Advertisement
LMAT
LeMaitre Vascular, Inc.
81.45
USDSponsored
+0.63
+0.78%
Aug 07, 15:59 UTC -4
Closed
After-Market
81.45
0.00
0.00%
LMAT Earnings Reports
Positive Surprise Ratio
LMAT beat 28 of 43 last estimates.
65%
Next Report
Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$70.63M
/$0.74
Implied change from Q2 26 (Revenue/ EPS)
+0.36%
/--
Implied change from Q3 25 (Revenue/ EPS)
+15.70%
/+19.35%
LeMaitre Vascular, Inc. earnings per share and revenue
On Aug 04, 2026, LMAT reported earnings of 0.74 USD per share (EPS) for Q2 26, missing the estimate of 0.82 USD, resulting in a -10.07% surprise. Revenue reached 70.38 million, compared to an expected 72.39 million, with a -2.78% difference. The market reacted with a -25.32% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 11 analysts forecast an EPS of 0.74 USD, with revenue projected to reach 70.63 million USD, implying an increase of 0.00% EPS, and increase of 0.36% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.02
Surprise
+54.65%
BioLife Solutions Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
Trulieve Cannabis Corp.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$0.06
Actual
$0.11
Surprise
+72.14%
Canopy Growth Corporation Common Shares
Report Date
Aug 07, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.02
Surprise
+75.74%
Apyx Medical Corporation Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+16.27%
ResMed Inc.
Report Date
Aug 06, 2026 For Q4 26
Estimate
$2.91
Actual
$2.95
Surprise
+1.09%
Lantheus Holdings, Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.31
Actual
$1.55
Surprise
+17.50%
ICU Medical Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.95
Actual
$2.37
Surprise
+21.43%
Haemonetics Corporation
Report Date
Aug 06, 2026 For Q1 27
Estimate
$1.08
Actual
$1.13
Surprise
+4.82%
United-Guardian, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
-Actual
$0.16
Surprise
-
FAQ
What were LeMaitre Vascular, Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, LeMaitre Vascular, Inc. reported EPS of $0.74, missing estimates by -10.07%, and revenue of $70.38M, -2.78% below expectations.
How did the market react to LeMaitre Vascular, Inc.'s Q2 2026 earnings?
The stock price moved down -25.32%, changed from $105.78 before the earnings release to $79.00 the day after.
When is LeMaitre Vascular, Inc. expected to report next?
The next earning report is scheduled for Nov 04, 2026.
What are the forecasts for LeMaitre Vascular, Inc.'s next earnings report?
Based on 11
analysts, LeMaitre Vascular, Inc. is expected to report EPS of $0.74 and revenue of $70.63M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement